Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma

Pazopanib is an oral multi-targeted tyrosine kinase inhibitor and has been approved for metastatic renal cell carcinoma and advanced soft tissue sarcoma. To the best of our knowledge, pazopanib-induced thyrotoxicosis has never been reported. The patient was a 68-year-old woman with renal cell carcin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Cancer Conf J
Autors principals: Kuribayashi, Sohei, Takao, Tetsuya, Okuda, Yohei, Kawamura, Masataka, Nakano, Kosuke, Kishimoto, Nozomu, Takezawa, Kentaro, Tanigawa, Go, Tsutahara, Koichi, Watanabe, Hirotaka, Umayahara, Yutaka, Yamaguchi, Seiji
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498272/
https://ncbi.nlm.nih.gov/pubmed/31149484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0288-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars